Search

Search bills, members, committees and pages...

VIVEX BIOLOGICS

16 federal lobbying filings, 2024 to 2026.

VIVEX BIOLOGICS is a client on 16 federal lobbying filings, 2024 to 2026, reporting $950K across them. regenerative medicine company Based in Florida.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

2 it has hired, by filings.

RegistrantFilingsReported
THE MCMANUS GROUP11$470K
CONTINENTAL STRATEGY, LLC5$480K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20264$340K
20257$440K
20245$170K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues16
MMMMedicare/Medicaid8
SCIScience/Technology5

Bills

The bills the filings name, by how many name them.

BillTitleFilings
S. 2561Skin Substitute Access and Payment Reform Act of 20254
H.R. 5768Skin Substitute Access and Payment Reform Act3
H.R. 6852Advanced Wound Care and Regenerative Medicine Access and Reform Act3

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
VIVEX BIOLOGICSTHE MCMANUS GROUP2026 second_quarter$50KJul 20, 2026
VIVEX BIOLOGICSCONTINENTAL STRATEGY, LLC2026 second_quarter$120KJul 19, 2026
VIVEX BIOLOGICSTHE MCMANUS GROUP2026 first_quarter$50KApr 20, 2026
VIVEX BIOLOGICSCONTINENTAL STRATEGY, LLC2026 first_quarter$120KApr 18, 2026
VIVEX BIOLOGICSTHE MCMANUS GROUP2025 fourth_quarter$50KJan 20, 2026
VIVEX BIOLOGICSCONTINENTAL STRATEGY, LLC2025 fourth_quarter$120KJan 20, 2026
VIVEX BIOLOGICSTHE MCMANUS GROUP2025 third_quarter$50KOct 20, 2025
VIVEX BIOLOGICSCONTINENTAL STRATEGY, LLC2025 third_quarter$120KOct 20, 2025
VIVEX BIOLOGICSCONTINENTAL STRATEGY, LLC2025 third_quarterAug 6, 2025
VIVEX BIOLOGICSTHE MCMANUS GROUP2025 second_quarter$50KJul 21, 2025
VIVEX BIOLOGICSTHE MCMANUS GROUP2025 first_quarter$50KApr 21, 2025
VIVEX BIOLOGICSTHE MCMANUS GROUP2024 fourth_quarter$50KJan 21, 2025
VIVEX BIOLOGICSTHE MCMANUS GROUP2024 third_quarter$50KOct 21, 2024
VIVEX BIOLOGICSTHE MCMANUS GROUP2024 second_quarter$50KJul 16, 2024
VIVEX BIOLOGICSTHE MCMANUS GROUP2024 first_quarter$20KApr 23, 2024
VIVEX BIOLOGICSTHE MCMANUS GROUP2024 first_quarterMar 27, 2024